Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Grant or award Director acquired 108,992 shares (grant or award)
  2. 4 Grant or award Director acquired 16,341 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 136,240 shares (grant or award)
  4. 4 Grant or award Director acquired 16,341 shares (grant or award)
  5. 4 Grant or award Director acquired 65,364 shares (grant or award)
  6. 4 Planned sale Chief Executive Officer sold 50,000 shares at an average $149.50 ($7,475,024)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $167.36 ($8,368,017)
  9. 4 Gift Director gave 82,020 shares (gift)
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Chief Financial Officer sold 397 shares at $167.08 ($66,331)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Gift Director gave 71,890 shares (gift)
  14. 4 Open-market sale Director sold 1,100,000 shares at $180.50 ($198,550,000)
  15. 4 Open-market sale SVP, General Counsel sold 791 shares at $216.26 ($171,059)
  16. 4 Open-market sale Chief Financial Officer sold 472 shares at $179.55 ($84,747)
  17. 4 Open-market sale Global Head of R&D sold 1,108 shares at an average $181.92 ($201,567)
  18. 4 Open-market sale Chief Financial Officer sold 840 shares at $182.85 ($153,594)
  19. 4 Planned sale Director sold 578 shares at an average $182.32 ($105,381)
  20. 4 Open-market sale President, COO & GM China sold 1,495 shares at $182.37 ($272,636)

Page 10 of 29 · 580 filings